ACE and endothelial dysfunction: Indeed, the severity of endothelial dysfunction in these conditions is heterogeneous and directly affected by medications such as Angiotensin II receptor blockers (ARB) and ACE-inhibitors44–46, which were used in 46.3% of patients in our cohort, but prescription rates were similar between severity groups.